Copasure 24g
Presentation
Large, maroon, hard gelatin capsules containing 24g copper oxide, equivalent 20.4 g metallic copper.
Uses
Copasure 24g is indicated for the prevention and treatment of copper deficiency. A proportion of the administered copper oxide lodges in the abomasum of the treated animal. This provides a sustained-release source of copper for absorption from the gut. This steady supplementation ensures adequate copper status but avoids the sharp rises in copper levels which can be associated with copper toxicity.
Dosage and Administration
Young cattle, 100 – 300 kg bodyweight: 1 x Copasure 24g capsule
Adult cattle, over 300 kg bodyweight: 1 or 2 x Copasure 24g capsules depending on the severity of deficiency.
(Ruminating calves, 75 to 100 kg, may be given 2 x Copinox 4g Ewe/Calf capsules.)
Administration of Copasure 24g to cattle should ensure adequate copper status for several months, even on severely deficient diets. Further doses may then be necessary depending on individual circumstances.
Contra-indications, warnings, etc
Animals should only be dosed if copper deficiency exists or is known to be a risk. For animal use only. Keep out of the reach of children.
Pharmaceutical Precautions
Gelatin capsules are relatively fragile; handle with care, and protect from moisture, heat and direct sunlight. Store in a dry place in the tightly closed original container.
Legal Category
PML
Package quantities
Copasure 24g capsules are available in packs containing 24 capsules.
Further information
Primary copper deficiency arises from a direct shortage of copper in the diet whereas secondary copper deficiency results from the antagonistic effects of elements such as molybdenum and sulphur upon absorption. Copasure 24g is an effective long acting supplement in both cases. The severity of copper deficiency, whether of primary or secondary origin, varies greatly from farm to farm. On most copper deficient sites one dose of Copasure 24g, given to grazing cattle at turnout, will maintain normocupraemia over the grazing season and leave animals with a substantial liver copper reserve at housing. It is impossible, however, to cover the full range of deficiency states with a simple dosing regime. Veterinary surgeons may need to adapt their advice to suit local conditions. The oral administration of copper obviates the risk of local lesions often associated with copper injections, as well as the risk of toxicity associated with too rapid a rise in blood copper concentration.
Marketing authorisation number
Vm 14016/4003.
